[Update on Current Care Guideline: Borderline personality disorder]

Area of Science:

• Psychiatry
• Clinical Psychology

Background:

• Borderline personality disorder (BPD) is a severe mental health condition characterized by emotional instability, behavioral dysregulation, and interpersonal relationship difficulties.
• While historically viewed as having a poor prognosis, recent understanding suggests a more favorable course.

Purpose of the Study:

• To summarize current understanding and treatment approaches for Borderline Personality Disorder.
• To highlight effective therapeutic interventions and pharmacotherapy options.

Main Methods:

• Review of existing literature on Borderline Personality Disorder treatment efficacy.
• Synthesis of findings regarding psychotherapeutic modalities and pharmacological interventions.

Main Results:

• Dialectical behavioral therapy, cognitive therapy, mentalization therapy, and transference-focused psychotherapy demonstrate effectiveness in treating BPD.
• Antipsychotics and mood stabilizers can manage various BPD symptoms.
• Selective serotonin reuptake inhibitors (SSRIs) may help with impulsivity and aggression.
• Hospital treatment is best managed in day hospital settings.
• Benzodiazepines should be avoided in BPD treatment.

Conclusions:

• Borderline personality disorder has a more favorable course than previously assumed.
• A combination of specialized psychotherapies and judicious pharmacotherapy, alongside appropriate hospital settings, offers effective management for BPD.